Liwoma SRL
Liwoma reported total assets of 289,010 € at the end of the 2025 financial year (annual accounts filed with the NBB on 22 Jul 2026).
The score of Liwoma shows with a free account.
See the score- Summary? / 5
- Balance sheet strength
- Liquidity
- Repayment capacity
- Profitability
- Trajectory
- Compliance and register
- Position in its sectorvs peers
- Supplier creditat 30 d
- Borrowing capacityborrowable
- Valuationcentral
Visible once signed in: create your account, the 14-day Pro trial is free.
Key figures 2025
Change 2023 → 2025: Equity +537 % Total assets +432 %
Accounts of the company itself (not consolidated).
The full file covers 3 financial years; a free account shows 2. →Deterministic calculation on the filed accounts, no AI. Dispute the score or report an error
Liwoma's annual accounts
Filed annual accounts
- Year ended 31 Dec 2025filed on 22 Jul 2026
- Year ended 31 Dec 2024filed on 02 Jul 2025
- Year ended 31 Dec 2023filed on 01 Jul 2024
Liwoma's financial analysis
- Solvency74.9%sector median: 44.2%
- Current ratio
- Net margin
- ROE
- Financial debt / EBITDA
- Interest coverage
- Days sales outstanding (DSO)
Management and control of Liwoma
Liwoma's publications in the Belgian Gazette
Company number, VAT number and registered office
- Company number (CBE)
- 0804.674.287
- VAT number
- BE0804674287
- Peppol
- Registered · 0208:0804674287 · as of 10 Nov 2026
- Legal form
- SRL
- Incorporated
- 09 Aug 2023
- Registered office
- 2550 Kontich
- Latest accounts
- 2025 · filed on 22 Jul 2026
- Activity
- Retail sale of pharmaceutical products (NACE 47730)
Liwoma (SRL) has been based in Kontich since 2023, active in: retail sale of pharmaceutical products. For 2025, it reports a net profit of 85,154 € and equity of 216,381 €; its revenue is not published. Its solvency stands at 74.9%, above the median of its sector (44.2%).
Companies similar to Liwoma
Companies in the same business, of comparable size and area, outside its group.
- Yascare Retail sale of pharmaceutical products Uccle · balance sheet 34,424 €
- Farmafender Retail sale of pharmaceutical products Zedelgem · balance sheet 269,880 €
- D-Pharma Retail sale of pharmaceutical products Brasschaat · balance sheet 226,463 €
- AVA-Rose Retail sale of pharmaceutical products Jette · balance sheet 381,859 €
- White-TO-Black Retail sale of pharmaceutical products Dilbeek · balance sheet 209,334 €
- Sarina Janssens Farma Retail sale of pharmaceutical products Bierbeek · balance sheet 136,654 €
- Karbon Plus Retail sale of pharmaceutical products Diksmuide · balance sheet 127,790 €
- Apocurae Retail sale of pharmaceutical products Kortemark · balance sheet 124,948 €
Frequently asked questions about Liwoma
What is the revenue of Liwoma?
Liwoma files its accounts in a format where revenue is optional: it is not published for 2025.
What is the VAT number of Liwoma?
In Belgium, the VAT number is the company number prefixed with BE: BE0804674287 for Liwoma, if the company is VAT-registered. Its company number (CBE) is 0804.674.287.
Where is the registered office of Liwoma?
According to the CBE register, the registered office of Liwoma is in 2550 Kontich.
What is the equity of Liwoma?
At the close of the 2025 financial year, the equity of Liwoma amounts to 216,381 €, a solvency of 74.9% of total assets.
Who manages Liwoma?
The register lists 1 active mandates at Liwoma. Names and roles are in the full file, with the deeds published in the Belgian Gazette.
The full file of Liwoma
Directors and mandates, ownership network, Gazette deeds, ten years of accounts and ratios, Excel export, and Idonis's analysis in one question.
Open the full file →